UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):

 

July 28, 2004

 

GILEAD SCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

0-19731

 

94-3047598

(State or other jurisdiction of
incorporation or organization)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

 

 

 

 

 

333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA

(Address of principal executive offices)

 

 

 

 

 

94404

(Zip Code)

 

 

 

 

 

(650) 574-3000

(Registrant’s telephone number, including area code)

 

 



 

ITEM 5.                  OTHER EVENTS

 

On July 28, 2004, Gilead Sciences, Inc., a Delaware corporation, issued a press release announcing that its Board of Directors has declared a stock dividend of one share of common stock for each outstanding share of the company’s common stock. A copy of the press release is filed as Exhibit 99.1 to this report.

 

ITEM 7.                  FINANCIAL STATEMENTS AND EXHIBITS

 

(c)           Exhibits

 

Exhibit
Number

 

Description

 

 

 

99.1

 

Press Release, issued by Gilead Sciences, Inc. on July 28, 2004

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

GILEAD SCIENCES, INC.

 

 

(registrant)

 

 

 

 

 

/s/  John F. Milligan

 

 

John F. Milligan
Executive Vice President and
Chief Financial Officer

 

 

 

 

Date:       July 28, 2004

 

 

 

3



 

Exhibit Index

 

Exhibit
Number

 

Description

 

 

 

99.1

 

Press Release, issued by Gilead Sciences, Inc. on July 28, 2004

 

4